Groupe LFB is a renowned pharmaceutical company specializing in life-derived medicines. With a strong focus on plasma-derived and recombinant medications, LFB plays a vital role in the healthcare industry. The company has a significant presence in France and prioritizes the safety and well-being of patients.

LFB offers a wide range of 15 hospital-prescribed medications, catering to therapeutic areas such as immunology, hemostasis, and intensive care. It is committed to bioproduction and operates five sites globally, four of which are in France. LFB is dedicated to rare diseases and strives to provide therapeutic solutions for patients by developing and commercializing cutting-edge medications.

As a responsible enterprise, LFB not only prioritizes ethical engagement but also ensures environmental, social, and economic responsibilities. The company fosters strong relationships with patient associations and continuously supports projects to improve patient well-being. Overall, LFB stands as a leader in the field of plasma-derived medicines, making a significant impact on public health